Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 2 days agoNot all hospitals have such experts available. Second, the company allowed some patients in the...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 3 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
FDA To Review New Alzheimer's Drug Leqembi and How Often Patients Get Medication
Healthline via AOL· 1 day agoA medication designed to slow early Alzheimer’s disease may soon have a new once-a-month dosing...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 3 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
WUSF 89.7· 3 days agoAll 11 committee members also recommended that doctors and patients have the option of halting...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
WKBT La Crosse· 3 days agoDonanemab works by helping the body remove amyloid plaque buildups in the brain that are a hallmark...
Alzheimer’s Foundation of America encouraged by new drug closer to FDA approval
WBRC Fox 6 Birmingham· 2 days agoFederal health advisers are recommending a new Alzheimer’s drug from Eli Lilly that slows the...
A New Drug Could Slow Alzheimer's. But Can Patients Get It?
Bloomberg· 1 day agoA New Drug Could Slow Alzheimer's. But Can Patients Get It? A new medicine from Eli Lilly will face...
Lilly Alzheimer's drug gets unanimous backing from FDA advisory panel
Reuters via Yahoo News· 3 days ago(Reuters) -Outside advisers to the U.S. Food and Drug Administration on Monday voted unanimously...
Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel
Medscape· 4 days agoAn 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded...